Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human liver RNA-seq data corresponding to uninfected non-malignant, HCV infected non-malignant, and HCV+ HCC tissue

ABSTRACT: We aimed to identify epigenetic regulators of transcription that may be involved in the development and the progression of HCV-associated HCC. We used directional RNAseq for transcriptome profiling that we correlate with genome wide DNA methylation data.

ORGANISM(S): Homo sapiens

PROVIDER: GSE82177 | GEO | 2016/10/17

SECONDARY ACCESSION(S): PRJNA324260

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Human liver HELP-tagging cytosine methylation data corresponding to uninfected non-malignant, HCV+ non-malignant, and HCV+ HCC tissue

Project description:We aimed to identify epigenetic regulators of transcription that may be involved in the development and the progression of HCV-associated HCC. Using HELP-tagging, we performed the highest resolution DNA methylation profiling of HCV-associated HCC to date, testing ~2 million loci throughout the human genome in liver biopsies from 30 patients, identifying changes starting in infected liver and maintained through carcinogenesis. We identified loci at which DNA methylation is consistently altered, beginning earlier in the course of neoplastic disease and progressing with disease advancement.

2016-10-17 | GSE82176 | GEO

Human liver RNA-seq and HELP-tagging data corresponding to uninfected non-malignant, HCV+ non-malignant, and HCV+ HCC tissue

Project description:Human liver RNA-seq and HELP-tagging data corresponding to uninfected non-malignant, HCV+ non-malignant, and HCV+ HCC tissue

| PRJNA324258 | ENA

RNA-Seq analysis of HCV-related HCC and NBNC-HCC tumor and non-tumor part gene analysis

Project description:We performed RNA-seq analysisfor 2 HCV-HCC and 3 NBNC-HCC tumor and non-tumor regions, total for 10 samples to find the lncRNAs candidates in HCV-related HCC.

2020-07-22 | GSE154211 | GEO

Human liver RNA-seq and HELP-tagging data corresponding to uninfected non-malignant, HCV+ non-malignant, and HCV+ HCC tissue

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-10-17 | GSE82178 | GEO

RMA expression data for liver samples from subjects with HCV, HCV-HCC, or normal liver

2009-01-08 | GSE14323 | GEO

CpG site methylation of HCV-cirrhotic, HCV-HCC, and normal liver tissues

Project description:In this study we used a high-throughput method for assaying methylation of CpG sites simultaneously in a single sample for identifying differences in methylation observed in tissues ranging from normal liver to pre-neoplastic (cirrhosis) and neoplastic (HCC) states. Since there are important clinical and prognostic differences among HCC patients due to etiology, this study was designed to focus on HCC due to HCV-infection, a more common etiology of HCC among Western countries cross-sectional: 20 cirrhosis, 20 HCC, and 16 normal patients, 87 arrays

2010-02-18 | E-GEOD-18081 | biostudies-arrayexpress

CpG site methylation of HCV-cirrhotic, HCV-HCC, and normal liver tissues

2010-02-19 | GSE18081 | GEO

Transcription profiling of human liver samples from subjects with hepatitis C virus (HCV), HCV-HCC, or normal liver

Project description:The role of chronic hepatitis C virus (HCV) in the pathogenesis of HCV-associated hepatocellular carcinoma (HCC) is not completely understood, particularly at the molecular level. We studied gene expression in normal, pre-malignant (cirrhosis), and tumor (HCC) liver tissues using Affymetrix GeneChips. Experiment Overall Design: Liver tissue samples were obtained from patients waiting for liver transplantation at one of the GR2HCC Centers. Additionally, normal liver and tumor samples were also obtained from the Liver Tissue Cell Distribution System. For each sample, RNA was extracted and hybridized to an Affymetrix GeneChip.

2009-01-18 | E-GEOD-14323 | biostudies-arrayexpress

Exon analysis of HCV tumor promoting effect

Project description:The hepatitis C virus (HCV) is one of the major risk factors for the development of hepatocellular carcinoma (HCC). Nevertheless, transgenic mice which express the whole HCV polyprotein (HCV-Tg) do not develop HCC. Whereas chronic HCV infection causes inflammation in patients, in HCV-Tg mice, the host immune reaction against viral proteins is lacking. We aimed to test the role of HCV proteins in HCC development on the background of chronic inflammation in vivo. We crossed the HCV-Tg mice which do not produce HCC with the Mdr2-knockout (Mdr2-KO) mice which develop inflammation-associated HCC, to generate Mdr2-KO/HCV-Tg mice. We studied the effect of the HCV transgene on tumor incidence, hepatocyte mitosis and apoptosis, and on gene expression in the liver of produced mice.

2009-03-22 | GSE12184 | GEO

Transcript analysis of HCV tumor promoting effect

2009-03-22 | GSE12183 | GEO